CONCURRENT MEASUREMENTS OF BLOOD-FLOW AND TRANS-CAPILLARY TRANSPORT IN AVIAN-SARCOMA VIRUS-INDUCED EXPERIMENTAL BRAIN-TUMORS - IMPLICATIONS FOR CHEMOTHERAPY

  • 1 January 1984
    • journal article
    • research article
    • Vol. 231  (3) , 724-735
Abstract
A blood-to-tissue transfer constant, K, and tissue blood flow, F, were measured concurrently in 7 rats with a total of 19 separate brain tumors induced by intracerebral inoculation of avian sarcoma virus. Regional and local measurements of K and F were obtained using double-label quantitative autoradiography with .alpha.-[14C]aminoisobutyric acid and [131I]iodoantipyrine, computerized microdensitometry and image analysis. Apparent tissue extraction fractions and capillary permeability-surface area products were calculated for different tumor regions, brain adjacent to tumor and tumor-free brian. The following observations were made: 5 histological categories of the tumors were found; significant local and regional variations of both K and F were typical in each group, resulting in marked regional variability of permeability-surface area products but more uniform values of apparent extraction fraction; the values of F, K, permeability-surface area products and apparent extraction fraction correlated poorly with morphological features of the tumors (necrosis, cellularity, cytology, location and size); the extraction fraction of .alpha.-aminoisobutyric acid was usually highest in tumor centers and then decreased in a gradient from tumor periphery through adjacent brain; and regardless of classification or histological features, capillary permeability and surface area, and not tissue perfusion or blood flow, seem to determine the blood-to-tissue transport processes (delivery of bloodborne materials) in most regions of these experimental brain tumors. An operationtal pharmacokinetic model of drug concentration in tumor tissue is developed and increases in capillary permeability such as measured in these studies would evidently not be sufficient to deliver adequate amounts of water-soluble drugs with short plasma half-lives to tumor tissue.